This antigen-independent homotypic BCR interaction on B CLL cells seems to affect the clinical course of disease as stronger affinity and longer half-life contacts are observed in indolent CLL, while weaker and more short-lived contacts are seen in aggressive CLL [53]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.